{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:07:08Z","timestamp":1788581228677,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10027-6","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:02:06Z","timestamp":1730811726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dynamic modelling of improved diagnostic testing for drug-resistant tuberculosis in high burden settings"],"prefix":"10.1186","volume":"24","author":[{"given":"Marya","family":"Getchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Pastor","family":"Ansah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dodge","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Basilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Tablizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surakameth","family":"Mahasirimongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waritta","family":"Sawaengdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Matchar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"10027_CR1","unstructured":"Global tuberculosis report. (World Health Organization, Geneva, 2023)."},{"key":"10027_CR2","unstructured":"The Global Plan to, End TB. 2023\u20132030. https:\/\/www.stoptb.org\/global-plan-to-end-tb\/global-plan-to-end-tb-2023-2030 (The Stop TB Partnership, UNOPS, Geneva, 2023)."},{"key":"10027_CR3","unstructured":"WHO consolidated guidelines on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detection, third edition. (World Health Organization, Geneva, 2024)."},{"key":"10027_CR4","doi-asserted-by":"publisher","first-page":"e1003008","DOI":"10.1371\/journal.pmed.1003008","volume":"17","author":"AS Dean","year":"2020","unstructured":"Dean AS, et al. Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: a multicountry analysis of cross-sectional data. PLoS Med. 2020;17:e1003008. https:\/\/doi.org\/10.1371\/journal.pmed.1003008.","journal-title":"PLoS Med"},{"key":"10027_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1473-3099(16)30407-8","volume":"17","author":"M Gegia","year":"2017","unstructured":"Gegia M, Winters N, Benedetti A, van Soolingen D, Menzies D. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17:223\u201334. https:\/\/doi.org\/10.1016\/S1473-3099(16)30407-8.","journal-title":"Lancet Infect Dis"},{"key":"10027_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S1473-3099(18)30673-X","volume":"19","author":"K Zurcher","year":"2019","unstructured":"Zurcher K, et al. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study. Lancet Infect Dis. 2019;19:298\u2013307. https:\/\/doi.org\/10.1016\/S1473-3099(18)30673-X.","journal-title":"Lancet Infect Dis"},{"key":"10027_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12879-022-07067-1","volume":"22","author":"M Karmakar","year":"2022","unstructured":"Karmakar M, Ragonnet R, Ascher DB, Trauer JM, Denholm JT. Estimating tuberculosis drug resistance amplification rates in high-burden settings. BMC Infect Dis. 2022;22:82. https:\/\/doi.org\/10.1186\/s12879-022-07067-1.","journal-title":"BMC Infect Dis"},{"key":"10027_CR8","doi-asserted-by":"publisher","first-page":"e0211355","DOI":"10.1371\/journal.pone.0211355","volume":"14","author":"K Romanowski","year":"2019","unstructured":"Romanowski K, et al. The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: a modelling study. PLoS ONE. 2019;14:e0211355. https:\/\/doi.org\/10.1371\/journal.pone.0211355.","journal-title":"PLoS ONE"},{"key":"10027_CR9","doi-asserted-by":"publisher","first-page":"e0183222","DOI":"10.1128\/jcm.01832-22","volume":"61","author":"X Chen","year":"2023","unstructured":"Chen X, et al. Rapid Detection of Extensive Drug Resistance by Xpert MTB\/XDR optimizes therapeutic decision-making in Rifampin-resistant tuberculosis patients. J Clin Microbiol. 2023;61:e0183222. https:\/\/doi.org\/10.1128\/jcm.01832-22.","journal-title":"J Clin Microbiol"},{"key":"10027_CR10","unstructured":"Use of targeted next-. generation sequencing to detect drug-resistant tuberculosis: rapid communication, July 2023. (World Health Organization)."},{"key":"10027_CR11","doi-asserted-by":"publisher","first-page":"102051","DOI":"10.1016\/j.tube.2021.102051","volume":"127","author":"P Kambli","year":"2021","unstructured":"Kambli P, et al. Targeted next generation sequencing directly from sputum for comprehensive genetic information on drug resistant Mycobacterium tuberculosis. Tuberculosis (Edinb). 2021;127:102051. https:\/\/doi.org\/10.1016\/j.tube.2021.102051.","journal-title":"Tuberculosis (Edinb)"},{"key":"10027_CR12","doi-asserted-by":"publisher","first-page":"1206056","DOI":"10.3389\/fpubh.2023.1206056","volume":"11","author":"SG Murphy","year":"2023","unstructured":"Murphy SG, et al. Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing. Front Public Health. 2023;11:1206056. https:\/\/doi.org\/10.3389\/fpubh.2023.1206056.","journal-title":"Front Public Health"},{"key":"10027_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jtbi.2014.05.023","volume":"358","author":"JM Trauer","year":"2014","unstructured":"Trauer JM, Denholm JT, McBryde ES. Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-Pacific. J Theor Biol. 2014;358:74\u201384. https:\/\/doi.org\/10.1016\/j.jtbi.2014.05.023.","journal-title":"J Theor Biol"},{"key":"10027_CR14","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1038\/s41598-022-07536-2","volume":"12","author":"MA Kuddus","year":"2022","unstructured":"Kuddus MA, McBryde ES, Adekunle AI, White LJ, Meehan MT. Mathematical analysis of a two-strain tuberculosis model in Bangladesh. Sci Rep. 2022;12:3634. https:\/\/doi.org\/10.1038\/s41598-022-07536-2.","journal-title":"Sci Rep"},{"key":"10027_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jgar.2022.03.018","volume":"29","author":"A Xu","year":"2022","unstructured":"Xu A, Wen ZX, Wang Y, Wang WB. Prediction of different interventions on the burden of drug-resistant tuberculosis in China: a dynamic modelling study. J Glob Antimicrob Resist. 2022;29:323\u201330. https:\/\/doi.org\/10.1016\/j.jgar.2022.03.018.","journal-title":"J Glob Antimicrob Resist"},{"key":"10027_CR16","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1016\/S1473-3099(18)30134-8","volume":"18","author":"NA Menzies","year":"2018","unstructured":"Menzies NA, et al. Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. Lancet Infect Dis. 2018;18:e228\u201338. https:\/\/doi.org\/10.1016\/S1473-3099(18)30134-8.","journal-title":"Lancet Infect Dis"},{"key":"10027_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.epidem.2017.06.002","volume":"21","author":"R Ragonnet","year":"2017","unstructured":"Ragonnet R, et al. Optimally capturing latency dynamics in models of tuberculosis transmission. Epidemics. 2017;21:39\u201347. https:\/\/doi.org\/10.1016\/j.epidem.2017.06.002.","journal-title":"Epidemics"},{"key":"10027_CR18","unstructured":"United Nations, Department of Economic and Social Affairs. Population Division. World Population Prospects: The 2022 Revision. <https:\/\/population.un.org\/wpp\/> (2022)."},{"key":"10027_CR19","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1093\/cid\/ciaa602","volume":"73","author":"R Ragonnet","year":"2021","unstructured":"Ragonnet R, et al. Revisiting the natural history of pulmonary tuberculosis: a bayesian estimation of Natural Recovery and Mortality Rates. Clin Infect Dis. 2021;73:e88\u201396. https:\/\/doi.org\/10.1093\/cid\/ciaa602.","journal-title":"Clin Infect Dis"},{"key":"10027_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S1473-3099(17)30247-5","volume":"17","author":"A Sharma","year":"2017","unstructured":"Sharma A, et al. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study. Lancet Infect Dis. 2017;17:707\u201315. https:\/\/doi.org\/10.1016\/S1473-3099(17)30247-5.","journal-title":"Lancet Infect Dis"},{"key":"10027_CR21","first-page":"500","volume":"13","author":"Philippine Nationwide Tuberculosis Drug Resistance Survey","year":"2009","unstructured":"Philippine Nationwide Tuberculosis Drug Resistance Survey. Nationwide drug resistance survey of tuberculosis in the Philippines. Int J Tuberc Lung Dis. 2009;13:500\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"10027_CR22","unstructured":"Second National Drug Resistance Survey on Tuberculosis in the Philippines. (Department of Health, Philippines, December 3, 2014)."},{"key":"10027_CR23","unstructured":"National Tuberculosis Prevalence Survey 2016 Philippines. (Department of Health - Disease Prevention and Control Bureau, Manila, Philippines, 2016)."},{"key":"10027_CR24","unstructured":"The WHO\/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Fourth Global Report. (World Health Organization, 2002\u20137)."},{"key":"10027_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/tmi.13502","volume":"26","author":"P Kamolwat","year":"2021","unstructured":"Kamolwat P, et al. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey. Trop Med Int Health. 2021;26:45\u201353. https:\/\/doi.org\/10.1111\/tmi.13502.","journal-title":"Trop Med Int Health"},{"key":"10027_CR26","unstructured":"National Tuberculosis Control Program, Manual of Procedures, 6th edition. (Department of Health, Philippines, 2020)."},{"key":"10027_CR27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1473-3099(19)30307-X","volume":"19","author":"GM Knight","year":"2019","unstructured":"Knight GM, McQuaid CF, Dodd PJ, Houben R. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling. Lancet Infect Dis. 2019;19:903\u201312. https:\/\/doi.org\/10.1016\/S1473-3099(19)30307-X.","journal-title":"Lancet Infect Dis"},{"key":"10027_CR28","doi-asserted-by":"publisher","first-page":"100443","DOI":"10.1016\/j.xgen.2023.100443","volume":"3","author":"PM Pronyk","year":"2023","unstructured":"Pronyk PM, et al. Advancing pathogen genomics in resource-limited settings. Cell Genom. 2023;3:100443. https:\/\/doi.org\/10.1016\/j.xgen.2023.100443.","journal-title":"Cell Genom"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10027-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10027-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10027-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:02:12Z","timestamp":1730811732000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10027-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10027"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10027-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"19 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No participant data was collected for this study. The study was granted exemption from IRB review from the Duke-NUS Departmental Ethics Review Committee (Reference: DERC-19-231205).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1247"}}